- DocumentoProtocol MS tratament SARS-COV2_23-05-2020.pdfcaricato da
John Smith
- DocumentoObesity, Type 2 Diabetes and Metformincaricato da
John Smith
- DocumentoLead Accumulation in Shin Bone Tied to Resistant Hypertension.pdfcaricato da
John Smith
- DocumentoHemoglobin Concentration and the Risk of Hemorrhagic and Ischemic Stroke in Patients Undergoing Hemodialysiscaricato da
John Smith
- DocumentoGrowth of Small Renal Masses Not Tied to Poor Outcomescaricato da
John Smith
- DocumentoH pylori Raises Phosphate Binder Pill Burden in Dialysis.pdfcaricato da
John Smith
- DocumentoGetting to the Bottom of Lupus Biologycaricato da
John Smith
- DocumentoGenetics and Lifestyle Additive for Cardiovascular Riskcaricato da
John Smith
- DocumentoCutting Carbs in Morning Equals Better Weight Loss, Waist Sizecaricato da
John Smith
- DocumentoCOVID-19 and Angiotensin Drugs_Help or Harmcaricato da
John Smith
- DocumentoCOVID19_AHA Guidance on Hypertension, Latest on Angiotensin Linkcaricato da
John Smith
- DocumentoAlnylam Gene-Silencing Therapy to Treat Kidney Disorder Succeeds in Late-Stage Studycaricato da
John Smith
- DocumentoAlcohol and the Electric Atrium_ How Drinking Promotes AF.pdfcaricato da
John Smith
- DocumentoBeing Overweight Wipes 4 Years From Life, New Report Reveals.pdfcaricato da
John Smith
- DocumentoTarget Patients With Gestational Diabetes After Birth to Reduce Riskscaricato da
John Smith
- DocumentoTherapeutic Advances in the Treatment of Polycystic Kidney Diseasecaricato da
John Smith
- DocumentoSerum Sodium Concentration Linked to Cognition in Older Mencaricato da
John Smith
- DocumentoEffects of Higher Quality of Care on Initiation of Long-term Dialysis in Patients With CKD and Diabetescaricato da
John Smith
- DocumentoHigh Death, Hospitalization Rates With Chronic Ischemic CV Diseasecaricato da
John Smith
- DocumentoFDA OKs Consensi for Osteoarthritis Pain and Hypertensioncaricato da
John Smith
- DocumentoFDA Panel Rejects Empagliflozin for Use in Type 1 Diabetes.pdfcaricato da
John Smith
- DocumentoFDA Panels Vote to Add Aspirin Warning to Naproxen Label.pdfcaricato da
John Smith
- DocumentoFDA OKs Novel Calcimimetic for Secondary Hyperparathyroidismcaricato da
John Smith
- DocumentoFDA OKs First Treatment for Pediatric Lupus.pdfcaricato da
John Smith
- DocumentoFDA OKs Vabomere, New Antibacterial for Complicated UTIcaricato da
John Smith
- DocumentoFDA Expands Indication for PCSK9 Alirocumab (Praluent).pdfcaricato da
John Smith
- DocumentoFDA Turns Down Sotagliflozin for Type 1 Diabetescaricato da
John Smith
- DocumentoFDA Warns of _Serious_ Respiratory Problems With Gabapentincaricato da
John Smith
- DocumentoFDA Not Recommending Recalls of Diabetes Drug Metformincaricato da
John Smith
- DocumentoFDA Panels Vote to Add Aspirin Warning to Naproxen Labelcaricato da
John Smith
- DocumentoFDA Panel Rejects Empagliflozin for Use in Type 1 Diabetes.pdfcaricato da
John Smith
- DocumentoFDA Investigating Metformin for Possible Carcinogencaricato da
John Smith
- DocumentoFDA Expands Indication for PCSK9 Alirocumab (Praluent).pdfcaricato da
John Smith
- DocumentoFDA Confirms _Dangerous_ Levels of Heavy Metals in Some Kratom Productscaricato da
John Smith
- DocumentoFDA Expands Auryxia Indication to CKD Patients Not on Dialysiscaricato da
John Smith
- DocumentoFDA Clears First Device for Treating ADHD.pdfcaricato da
John Smith
- DocumentoCOVID19 - More Hydroxychloroquine Data From France, More Questionscaricato da
John Smith
- Documentocap4-strategia-didactica-metode-si-procedee-didactice.pdfcaricato da
John Smith
- DocumentoAtezolizumab Safe in Advanced Urothelial Cancercaricato da
John Smith
- DocumentoContrast-Induced Kidney Injury Risk Low in CKD, May Be Preventable.pdfcaricato da
John Smith
- DocumentoSchizophrenia - Volume I_2nd Edition.pdfcaricato da
John Smith
- DocumentoAutism Spectrum Disorderscaricato da
John Smith
- DocumentoKDIGO-CKD Management Guide.pdfcaricato da
John Smith
- DocumentoKDIGO-Glomerulonephritis Management Guide.pdfcaricato da
John Smith
- DocumentoKDIGO-Blood Pressure in CKD Guide.pdfcaricato da
John Smith
- DocumentoKDIGO-Anemia in CKD Guide.pdfcaricato da
John Smith
- DocumentoKDIGO-Acute Kidney Injury Guide.pdfcaricato da
John Smith
- DocumentoVericiguat Seen as Novel Success in Tough-to-Treat, High-Risk Heart Failurecaricato da
John Smith
- DocumentoRenal Denervation Shown Safe and Effective in Pivotal Trialcaricato da
John Smith